Published in Curr Opin Lipidol on April 01, 2012
Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. J Clin Invest (2013) 1.57
Bile acid metabolism and signaling. Compr Physiol (2013) 1.42
The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance. Cell Rep (2015) 1.40
A novel approach to oral apoA-I mimetic therapy. J Lipid Res (2013) 1.09
Adipose triglyceride lipase is a TG hydrolase of the small intestine and regulates intestinal PPARα signaling. J Lipid Res (2012) 0.98
Relative roles of ABCG5/ABCG8 in liver and intestine. J Lipid Res (2014) 0.96
A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion. Trends Pharmacol Sci (2015) 0.91
New developments in selective cholesteryl ester uptake. Curr Opin Lipidol (2013) 0.85
Intestinal SR-BI does not impact cholesterol absorption or transintestinal cholesterol efflux in mice. J Lipid Res (2013) 0.83
Differential impact of hepatic deficiency and total body inhibition of MTP on cholesterol metabolism and RCT in mice. J Lipid Res (2014) 0.83
Acute sterol o-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretion. PLoS One (2014) 0.81
Liver X receptors at the intersection of lipid metabolism and atherogenesis. Atherosclerosis (2015) 0.81
Acceleration of biliary cholesterol secretion restores glycemic control and alleviates hypertriglyceridemia in obese db/db mice. Arterioscler Thromb Vasc Biol (2013) 0.81
Insig proteins mediate feedback inhibition of cholesterol synthesis in the intestine. J Biol Chem (2013) 0.80
Cholesterol and lipoprotein metabolism: Early Career Committee contribution. Arterioscler Thromb Vasc Biol (2014) 0.78
Effects of LDL Receptor Modulation on Lymphatic Function. Sci Rep (2016) 0.78
From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport. Pharmacol Res (2013) 0.78
Reduction of VLDL secretion decreases cholesterol excretion in niemann-pick C1-like 1 hepatic transgenic mice. PLoS One (2014) 0.78
Selective evaluation of high density lipoprotein from mouse small intestine by an in situ perfusion technique. J Lipid Res (2014) 0.77
Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux. J Lipid Res (2016) 0.76
Phospholipid transfer protein deficiency in mice impairs macrophage reverse cholesterol transport in vivo. Exp Biol Med (Maywood) (2016) 0.76
Dynamics of hepatic and intestinal cholesterol and bile acid pathways: The impact of the animal model of estrogen deficiency and exercise training. World J Hepatol (2016) 0.76
Caveolae and Caveolin-1 Integrate Reverse Cholesterol Transport and Inflammation in Atherosclerosis. Int J Mol Sci (2016) 0.76
Impact of Inhibiting Ileal Apical versus Basolateral Bile Acid Transport on Cholesterol Metabolism and Atherosclerosis in Mice. Dig Dis (2015) 0.75
Trust your gut: galvanizing nutritional interest in intestinal cholesterol metabolism for protection against cardiovascular diseases. Nutrients (2013) 0.75
Hepatic or intestinal ABCG5 and ABCG8 are sufficient to block the development of sitosterolemia. J Lipid Res (2014) 0.75
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med (2011) 13.55
The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest (1968) 5.80
LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science (2009) 5.23
Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J (1988) 4.54
Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol (2008) 4.29
Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J Lipid Res (1993) 3.64
Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci U S A (2002) 3.09
Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Invest (2007) 3.01
Gallstone disease: Epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol (2006) 2.73
The metabolic role of lecithin: cholesterol acyltransferase: perspectives form pathology. Adv Lipid Res (1973) 2.12
Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss. J Biol Chem (2008) 2.09
Cholesterol balance and metabolism in mice with loss of function of Niemann-Pick C protein. Am J Physiol (1999) 1.90
Control of cholesterol turnover in the mouse. J Biol Chem (2001) 1.78
Cholesterol synthesis by the gastrointestinal tract: localization and mechanisms of control. J Clin Invest (1965) 1.75
A physiological method for estimation of hepatic secretion of biliary lipids in man. Gastroenterology (1972) 1.73
Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol. J Biol Chem (2009) 1.71
Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice. Gastroenterology (2007) 1.69
Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. J Biol Chem (2003) 1.67
Phospholipid transfer protein is regulated by liver X receptors in vivo. J Biol Chem (2002) 1.59
Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. J Biol Chem (2002) 1.50
Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice. Gastroenterology (2005) 1.50
Absorption of cholesterol from a micellar solution: intestinal perfusion studies in man. J Clin Invest (1967) 1.46
Future therapeutic directions in reverse cholesterol transport. Curr Atheroscler Rep (2010) 1.46
Biliary sterol secretion is not required for macrophage reverse cholesterol transport. Cell Metab (2010) 1.45
Ternary and quaternary aqueous systems containing bile salt, lecithin, and cholesterol. Nature (1966) 1.44
Regulation of reverse cholesterol transport and clinical implications. Am J Cardiol (2003) 1.44
The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2. J Biol Chem (2010) 1.44
Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism. Curr Opin Lipidol (2008) 1.40
Transintestinal cholesterol efflux. Curr Opin Lipidol (2010) 1.39
The role of bile salts in controlling the rate of intestinal cholesterogenesis. J Clin Invest (1968) 1.31
Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL. J Clin Invest (2001) 1.28
Centripetal cholesterol flux to the liver is dictated by events in the peripheral organs and not by the plasma high density lipoprotein or apolipoprotein A-I concentration. J Lipid Res (1998) 1.28
Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis. Cell Metab (2010) 1.20
Accelerated lipid absorption in mice overexpressing intestinal SR-BI. J Biol Chem (2006) 1.19
Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8. J Lipid Res (2008) 1.19
Regulation of direct transintestinal cholesterol excretion in mice. Am J Physiol Gastrointest Liver Physiol (2008) 1.17
Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice. Gastroenterology (2010) 1.16
Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol. Hepatology (2007) 1.15
ABCA1 plays no role in the centripetal movement of cholesterol from peripheral tissues to the liver and intestine in the mouse. J Lipid Res (2009) 1.14
Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo. Arterioscler Thromb Vasc Biol (2010) 1.13
Regulation of cholesterol metabolism in the dog. I. Effects of complete bile diversion and of cholesterol feeding on absorption, synthesis, accumulation, and excretion rates measured during life. J Clin Invest (1973) 1.10
Enlargement of high density lipoprotein in mice via liver X receptor activation requires apolipoprotein E and is abolished by cholesteryl ester transfer protein expression. J Biol Chem (2003) 1.04
Reverse cholesterol transport revisited: contribution of biliary versus intestinal cholesterol excretion. Arterioscler Thromb Vasc Biol (2011) 1.03
Function of the Niemann-Pick type C proteins and their bypass by cyclodextrin. Curr Opin Lipidol (2011) 1.03
Secretion of cholesterol by intestinal mucosa in patients with complete common bile duct obstruction. Proc Soc Exp Biol Med (1959) 1.01
Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux. J Lipid Res (2009) 0.97
From blood to gut: direct secretion of cholesterol via transintestinal cholesterol efflux. World J Gastroenterol (2010) 0.93
Do mammalian NPC1 and NPC2 play a role in intestinal cholesterol absorption? Biochem J (2007) 0.92
A reappraisal of the mechanism by which plant sterols promote neutral sterol loss in mice. PLoS One (2011) 0.90
A new framework for reverse cholesterol transport: non-biliary contributions to reverse cholesterol transport. World J Gastroenterol (2010) 0.89
Ezetimibe stimulates faecal neutral sterol excretion depending on abcg8 function in mice. FEBS Lett (2010) 0.85
Rat small intestine expresses the reelin-Disabled-1 signalling pathway. Exp Physiol (2009) 0.84
Role of cholesterol synthesis in regulation of bile acid synthesis and biliary cholesterol secretion in humans. J Lipid Res (1991) 0.80
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med (2013) 9.44
Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J Biol Chem (2008) 2.87
Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome. Curr Opin Lipidol (2009) 1.87
Liver-specific inhibition of acyl-coenzyme a:cholesterol acyltransferase 2 with antisense oligonucleotides limits atherosclerosis development in apolipoprotein B100-only low-density lipoprotein receptor-/- mice. Arterioscler Thromb Vasc Biol (2006) 1.83
Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake. J Biol Chem (2005) 1.75
Biliary sterol secretion is not required for macrophage reverse cholesterol transport. Cell Metab (2010) 1.45
Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production. J Biol Chem (2005) 1.26
Scavenger receptor class B type I is a plasma membrane cholesterol sensor. Circ Res (2012) 1.13
CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance. Proc Natl Acad Sci U S A (2013) 1.12
Inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilization. J Biol Chem (2010) 1.11
CGI-58/ABHD5-derived signaling lipids regulate systemic inflammation and insulin action. Diabetes (2012) 1.04
Conjugated linoleic acid reduces adiposity and increases markers of browning and inflammation in white adipose tissue of mice. J Lipid Res (2013) 1.01
Tissue-specific knockouts of ACAT2 reveal that intestinal depletion is sufficient to prevent diet-induced cholesterol accumulation in the liver and blood. J Lipid Res (2012) 0.94
Cancer stem cell-specific scavenger receptor 36 drives glioblastoma progression. Stem Cells (2014) 0.89
Adipose-selective overexpression of ABHD5/CGI-58 does not increase lipolysis or protect against diet-induced obesity. J Lipid Res (2011) 0.89
Diosgenin stimulation of fecal cholesterol excretion in mice is not NPC1L1 dependent. J Lipid Res (2009) 0.88
Intestinal SR-BI does not impact cholesterol absorption or transintestinal cholesterol efflux in mice. J Lipid Res (2013) 0.83
Phytosterol feeding causes toxicity in ABCG5/G8 knockout mice. Am J Pathol (2013) 0.82
Distinct roles for alpha-beta hydrolase domain 5 (ABHD5/CGI-58) and adipose triglyceride lipase (ATGL/PNPLA2) in lipid metabolism and signaling. Adipocyte (2012) 0.81
Emerging roles of flavin monooxygenase 3 in cholesterol metabolism and atherosclerosis. Curr Opin Lipidol (2015) 0.78
The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue. Cell Rep (2017) 0.75